B · Normal
[Novartis Pharmaceuticals fell more than 13% before the market opened] On September 8, Novartis Pharmaceuticals fell more than 13% before the market opened. It suffered its third clinical trial setback in the previous week.
Global market intelligence 🕐 2026-09-08 16:01

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet